Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Mar 15, 2023; 14(3): 343-346
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.343
Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.343
Ca2+/cAMP ratio: An inflammatory index for diabetes, hypertension, and COVID-19
Leandro Bergantin, Department of Pharmacology, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil
Author contributions: Bergantin LB is the sole author.
Conflict-of-interest statement: There are no conflicts of interest to report.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Leandro Bergantin, PhD, Professor, Department of Pharmacology, Universidade Federal de São Paulo, Rua Pedro de Toledo, 669 Vila Clementino, São Paulo 04039-032, Brazil. leanbio39@yahoo.com.br
Received: November 13, 2022
Peer-review started: November 13, 2022
First decision: December 1, 2022
Revised: December 11, 2022
Accepted: February 8, 2023
Article in press: February 8, 2023
Published online: March 15, 2023
Processing time: 122 Days and 2.8 Hours
Peer-review started: November 13, 2022
First decision: December 1, 2022
Revised: December 11, 2022
Accepted: February 8, 2023
Article in press: February 8, 2023
Published online: March 15, 2023
Processing time: 122 Days and 2.8 Hours
Core Tip
Core Tip: Ca2+/cAMP ratio could serve as an inflammatory index for diseases like hypertension, diabetes, and coronavirus disease 2019.